Kokudo T, Kokudo N
Cancers (Basel). 2025; 17(3).
PMID: 39941874
PMC: 11815920.
DOI: 10.3390/cancers17030507.
Yang G, Chen Y, Wang M, Wang H, Chen Y
Oncologist. 2024; 30(2).
PMID: 39475355
PMC: 11884753.
DOI: 10.1093/oncolo/oyae286.
Birgin E, Nebelung H, Abdelhadi S, Rink J, Froelich M, Hetjens S
Front Oncol. 2024; 14:1360936.
PMID: 39376989
PMC: 11457731.
DOI: 10.3389/fonc.2024.1360936.
Tang B, Wu F, Peng L, Leng X, Han Y, Wang Q
Cancer Imaging. 2024; 24(1):131.
PMID: 39367492
PMC: 11451056.
DOI: 10.1186/s40644-024-00781-w.
Gu M, Zhang S, Zou W, Zhao X, Chen H, He R
Abdom Radiol (NY). 2024; .
PMID: 39333413
DOI: 10.1007/s00261-024-04463-w.
Reply to correspondence on "Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis".
Attia A, Adetyan H, Yang J
Clin Mol Hepatol. 2024; 30(4):1042-1043.
PMID: 39188232
PMC: 11540384.
DOI: 10.3350/cmh.2024.0685.
Correspondence to editorial on "Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging".
Kim H, Lee D, Hwang Y
Clin Mol Hepatol. 2024; 30(4):992-993.
PMID: 39103995
PMC: 11540360.
DOI: 10.3350/cmh.2024.0624.
Preoperative prediction of microvascular invasion: new insights into personalized therapy for early-stage hepatocellular carcinoma.
Wang F, Liao H, Chen X, Lei H, Luo G, Chen G
Quant Imaging Med Surg. 2024; 14(7):5205-5223.
PMID: 39022260
PMC: 11250313.
DOI: 10.21037/qims-24-44.
Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI.
Zhang J, Li Y, Xia J, Pan X, Lu L, Fu J
J Hepatocell Carcinoma. 2024; 11:941-952.
PMID: 38813100
PMC: 11135558.
DOI: 10.2147/JHC.S459686.
Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection.
Gu K, Min J, Lee J, Shin J, Jeong W, Kim Y
Eur Radiol. 2024; 34(11):7002-7012.
PMID: 38767659
DOI: 10.1007/s00330-024-10780-x.
Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection.
Kim N, Bae H, Hwang H, Han D, Kim K, Choi J
Liver Cancer. 2024; 13(2):181-192.
PMID: 38751555
PMC: 11095589.
DOI: 10.1159/000531786.
Predicting microvascular invasion in hepatocellular carcinoma with a CT- and MRI-based multimodal deep learning model.
Lei Y, Feng B, Wan M, Xu K, Cui J, Ma C
Abdom Radiol (NY). 2024; 49(5):1397-1410.
PMID: 38433144
DOI: 10.1007/s00261-024-04202-1.
Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
Fujita N, Ushijima Y, Ishimatsu K, Okamoto D, Wada N, Takao S
Abdom Radiol (NY). 2024; 49(5):1467-1478.
PMID: 38360959
DOI: 10.1007/s00261-023-04179-3.
Comparison contrast-enhanced CT with contrast-enhanced US in diagnosing combined hepatocellular-cholangiocarcinoma: a propensity score-matched study.
Yang J, Zhang Y, Bao W, Chen Y, Jiang H, Huang J
Insights Imaging. 2024; 15(1):44.
PMID: 38353807
PMC: 10866845.
DOI: 10.1186/s13244-023-01576-6.
Outcomes of different parenchymal-sparing hepatectomies in patients with colorectal liver metastases and prognostic impact of peritumoral imaging features.
Liu L, Xie L, Zhou Y, Li Q, Lei X, Tang H
Abdom Radiol (NY). 2023; 48(12):3728-3745.
PMID: 37750923
DOI: 10.1007/s00261-023-04044-3.
Radiomics model based on contrast-enhanced CT texture features for pretreatment prediction of overall survival in esophageal neuroendocrine carcinoma.
Zhou Y, Song L, Xia J, Liu H, Xing J, Gao J
Front Oncol. 2023; 13:1225180.
PMID: 37664013
PMC: 10473874.
DOI: 10.3389/fonc.2023.1225180.
Clinical Interpretability of Deep Learning for Predicting Microvascular Invasion in Hepatocellular Carcinoma by Using Attention Mechanism.
You H, Wang J, Ma R, Chen Y, Li L, Song C
Bioengineering (Basel). 2023; 10(8).
PMID: 37627833
PMC: 10451856.
DOI: 10.3390/bioengineering10080948.
Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
Cha D, Kang T, Jeong W, Kim J, Choi G, Joh J
Eur Radiol. 2023; 34(1):498-508.
PMID: 37505248
DOI: 10.1007/s00330-023-09936-y.
A radiomics nomogram based on contrast-enhanced CT for preoperative prediction of Lymphovascular invasion in esophageal squamous cell carcinoma.
Wang Y, Bai G, Huang W, Zhang H, Chen W
Front Oncol. 2023; 13:1208756.
PMID: 37465108
PMC: 10351375.
DOI: 10.3389/fonc.2023.1208756.
Combined early dynamic F-FDG PET/CT and conventional whole-body F-FDG PET/CT in hepatocellular carcinoma.
Zhang Y, Dong Y, Yu W, Chen S, Yu H, Li B
Abdom Radiol (NY). 2023; 48(10):3127-3134.
PMID: 37439840
DOI: 10.1007/s00261-023-03986-y.